Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05911061
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-23
First Post:
2023-06-19
Brief Title:
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent XBBBA5Delta Protein Vaccine Sf9 Cell in Booster Vaccination
Sponsor:
Organization:
WestVac Biopharma Co Ltd